ArticleJournal of molecular modeling2021

Prospecting the therapeutic edge of a novel compound (B12) over berberine in the selective targeting of Retinoid X Receptor in colon cancer.

Temitayo I Subair et al.PubMed ↗Publisher ↗

No numbers read from the abstract.